Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells

NCT05628545 is registered in ClinicalTrials.gov with Guangdong GD Kongming Biotech LLC as lead sponsor.

NCT NCT05628545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05628545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells
Lead sponsor
Guangdong GD Kongming Biotech LLC
Phase
Phase 1/2
Overall status
Withdrawn
Start date
November 1, 2021
Completion date
October 31, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced hepatocellular carcinoma